Home > Healthcare > Pharmaceuticals > Finished Drug Form > Viscosupplementation Market

Viscosupplementation Market Size

Report ID: GMI4212
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Viscosupplementation Market Size

Viscosupplementation Market size was worth USD 3.6 billion in 2022. Driven by the high prevalence of osteoarthritis among the aging population, the industry is poised to record more than 9% CAGR from 2023 to 2032.

To get key market trends

Download Free Sample

Geriatric people are more susceptible to various health conditions, including osteoarthritis due to age-related changes in the body, such as diminished cartilage repair ability and changes in joint structure, which contribute to the disease's development and progression. In recent years, viscosupplementation has emerged as a popular treatment option for managing symptoms and improving joint function. The technique has a high acceptance rate among patients who have not received adequate relief from conservative therapies, promoting market expansion.

Besides, scientists and researchers worldwide have been working on prospects and undertaking efforts to enhance the molecular structure and characteristics of hyaluronic acid. This will help increase its viscosity, durability, and lubricating effects in joints, which, in consequence, will favor the market dynamics.

Viscosupplementation Market Report Attributes
Report Attribute	Details
Base Year:	2022
Viscosupplementation Market Size in 2022:	USD 3.6 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	9.2%
2032 Value Projection:	USD 8.7 Billion
Historical Data for:	2018 to 2022
No. of Pages:	150
Tables, Charts & Figures:	268
Segments covered:	Product, Source of Origin, End-use, and Region
Growth Drivers:	Growing geriatric population prone to osteoarthritis Rising demand for minimally invasive treatments Technological advancements Increasing preference for single injection treatment
Pitfalls & Challenges:	High cost of hyaluronic acid treatment Presence of alternatives for knee osteoarthritis treatment

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for viscosupplementation generated USD 3.6 billion in 2022 and is projected to grow at over a 9% CAGR from 2023 to 2032 attributed to the increasing prevalence of osteoarthritis among the geriatric population.

Single injection segment reached around USD 1.4 billion in 2022, attributed to the growing patient preference for single injection viscosupplementation technique.

The North America viscosupplementation market is set to amass around USD 3.4 billion by 2032, driven by the rising prevalence of arthritis and other bone-related disorders across the region.

The global viscosupplementation industry includes major companies such as Zimmer Biomet OrthogenRX, Anika Therapeutics, Inc., and Bioventus, among others.